Skip to content

Clinical trials

Phase 2 Fanconi Anemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fanconi Anemia Phase: Phase 2 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20071
20091
20131
20141
20161
20185
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
Children's Hospital Medical Center, Cincinnati2
Masonic Cancer Center, University of Minnesota2
Boston Children's Hospital1
Dana-Farber Cancer Institute1
Emory University1
Fred Hutchinson Cancer Center1
Hospital Universitari Vall d'Hebron Research Institute1
Julian Sevilla1
Medical College of Wisconsin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fanconi Anemia19
Myelodysplastic Syndromes6
Anemia, Aplastic5
Dyskeratosis Congenita3
Hematologic Diseases3
Leukemia3
Leukemia, Myeloid, Acute3
Anemia, Refractory, with Excess of Blasts2
Bone Marrow Failure Disorders2
Burkitt Lymphoma2

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.